Abstract
Background and purpose
When treated by radiotherapy, patients with squamous cell carcinomas of the head and neck (HNSCC) positive for HPV and p16(INK4a) possess a clearly favorable prognosis as compared to those with HPV-negative HNSCC. The aim of this work was to study whether the better outcomes might be caused by an enhanced cellular radiosensitivity.Materials and methods
The radiation response of five HPV/p16(INK4a)-positive and five HPV-negative cell lines was characterized with regard to cellular radiosensitivity by colony formation assay. Furthermore G1- and G2-arrest, apoptosis and residual DNA double-strand breaks (DSB) were analyzed by the colcemid-based G1-efflux assay, propidium iodide staining, the detection of PARP cleavage, the fluorescence-based detection of caspase activity and the immunofluorescence staining of γH2AX and 53BP1 foci.Results
On average, the cellular radiosensitivity of the HNSCC cell lines positive for HPV and p16(INK4a) was higher as compared to the sensitivity of a panel of five HPV-negative HNSCC cell lines (SF3=0.2827 vs. 0.4455). The higher sensitivity does not result from increased apoptosis or the execution of a permanent G1-arrest, but is rather associated with both, elevated levels of residual DSBs and extensive G2-arrest.Conclusions
Increased cellular radiosensitivity due to compromised DNA repair capacity is likely to contribute to the improved outcome of patients with HPV/p16(INK4a)-positive tumors when treated by radiotherapy.References
Articles referenced by this article (25)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
J Natl Cancer Inst, (9):709-720 2000
MED: 10793107
HPV-associated head and neck cancer: a virus-related cancer epidemic.
Lancet Oncol, (8):781-789 2010
MED: 20451455
Human papillomavirus oncoproteins: pathways to transformation.
Nat Rev Cancer, (8):550-560 2010
MED: 20592731
Human papillomavirus and survival of patients with oropharyngeal cancer.
N Engl J Med, (1):24-35 2010
MED: 20530316
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
J Clin Oncol, (12):1992-1998 2009
MED: 19289615
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
J Clin Oncol, (36):5630-5636 2006
MED: 17179101
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.
Radiother Oncol, (1):49-56 2012
MED: 22410204
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
J Clin Oncol, (5):736-747 2006
MED: 16401683
Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Radiother Oncol, (3):304-310 2007
MED: 17517444
Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.
Clin Cancer Res, (5):1257-1267 2012
MED: 22247495
Show 10 more references (10 of 25)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.radonc.2013.03.013
Article citations
Advancements in TGF-β Targeting Therapies for Head and Neck Squamous Cell Carcinoma.
Cancers (Basel), 16(17):3047, 31 Aug 2024
Cited by: 0 articles | PMID: 39272905 | PMCID: PMC11394608
Review Free full text in Europe PMC
Molecular Mechanisms Underlying the Anticancer Properties of Pitavastatin against Cervical Cancer Cells.
Int J Mol Sci, 25(14):7915, 19 Jul 2024
Cited by: 0 articles | PMID: 39063157 | PMCID: PMC11277542
Exploring the protective association between COVID-19 infection and laryngeal cancer: insights from a Mendelian randomization study.
Front Immunol, 15:1380982, 10 Jun 2024
Cited by: 0 articles | PMID: 38915416 | PMCID: PMC11194353
Radiobiology of Proton Therapy in Human Papillomavirus-Negative and Human Papillomavirus-Positive Head and Neck Cancer Cells.
Cancers (Basel), 16(11):1959, 22 May 2024
Cited by: 0 articles | PMID: 38893080 | PMCID: PMC11171379
High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma - A DAHANCA 19 study.
Clin Transl Radiat Oncol, 46:100772, 30 Mar 2024
Cited by: 0 articles | PMID: 38596816 | PMCID: PMC11002542
Go to all (195) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.
Oncogene, 36(6):820-828, 18 Jul 2016
Cited by: 27 articles | PMID: 27425591 | PMCID: PMC5434711
HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1.
Radiother Oncol, 108(3):495-499, 07 Aug 2013
Cited by: 29 articles | PMID: 23932155
Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells.
Radiother Oncol, 108(3):500-505, 13 Aug 2013
Cited by: 63 articles | PMID: 23953409
The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck.
Diagn Cytopathol, 42(1):85-93, 08 Jun 2013
Cited by: 22 articles | PMID: 23749770
Review